Fulgent Therapeutics LLC
Fulgent Therapeutics LLC, a leading player in the biotechnology sector, is headquartered in the United States and operates across various regions, focusing on advanced genomic testing and diagnostics. Founded in 2016, the company has rapidly established itself as a pioneer in the field, offering a comprehensive suite of services that includes genetic testing, next-generation sequencing, and custom assay development. Fulgent's core products are distinguished by their high accuracy and rapid turnaround times, catering to both clinical and research applications. The company has achieved significant milestones, including partnerships with healthcare providers and institutions, enhancing its market position as a trusted provider of innovative genomic solutions. With a commitment to advancing precision medicine, Fulgent Therapeutics continues to make strides in transforming patient care through cutting-edge technology and personalised diagnostics.
DitchCarbon Score
How does Fulgent Therapeutics LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Fulgent Therapeutics LLC's score of 3 is lower than 73% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Fulgent Therapeutics LLC's reported carbon emissions
Fulgent Therapeutics LLC, headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may be engaged in various initiatives to address climate change, as is common in the biotechnology sector. As the industry increasingly focuses on sustainability, Fulgent Therapeutics may adopt practices aimed at reducing environmental impact in the future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Fulgent Therapeutics LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
